Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Axonal Degeneration and Regeneration
Authors:
- 23 December 2016
- book chapter
- Published by Springer Nature
- p. 365-372
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Nodal proteins are target antigens in Guillain‐Barré syndromeJournal of the Peripheral Nervous System, 2012
- Anti-ganglioside antibodies alter presynaptic release and calcium influxNeurobiology of Disease, 2007
- LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survivalNature Medicine, 2002
- Intravenous immunoglobulins neutralize blocking antibodies in Guillain‐Barré syndromeAnnals of Neurology, 2002
- Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathyBrain, 2001
- Sural nerve T-cell receptor Vβ gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathyNeurology, 2001
- Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiersCurrent Opinion in Neurology, 1999
- Neuromuscular blockade by IgG antibodies from patients with Guillain‐Barré syndrome: A macro‐patch‐clamp studyAnnals of Neurology, 1998
- Ciliary neurotrophic factor: Pharmacokinetics and acute‐phase response in ratAnnals of Neurology, 1994
- The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disordersAnnals of Neurology, 1993